Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neural Control of Gait & Navigation in ADRD

NCT: NCT06501820 · RECRUITING

NCT IDNCT06501820
StatusRECRUITING
Start Date2025-11-13
Completion2030-05-01
SponsorUniversity of Florida (OTHER)
First posted
Last updated

Brief Summary

Brain network segregation, or independent functioning, declines with age and is associated with slower walking speed. Here, the investigators will determine the extent to which brain vestibular network segregation can be altered with bilateral vestibular cortical transcranial direct current stimulation (tDCS) in older adults with subjective cognitive decline. Participants will be randomly assigned to an active or sham stimulation condition. They will receive three, 20-minute sessions of tDCS while they are walking and performing cognitive tasks. MRI of the brain will be acquired before and after these three sessions.

Frequently Asked Questions

What is Neural Control of Gait & Navigation in ADRD?

Neural Control of Gait & Navigation in ADRD is a clinical trial registered under NCT06501820. Current status: RECRUITING.

What is the status of NCT06501820?

The current status of NCT06501820 (Neural Control of Gait & Navigation in ADRD) is: RECRUITING.

When did Neural Control of Gait & Navigation in ADRD start?

Neural Control of Gait & Navigation in ADRD started on 2025-11-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.